|  | MAPT (%) |  | ||
---|---|---|---|---|---|
Parameter | N | Negative | Low | High | P |
All cancers | 12,313 | 91.8 | 7.1 | 1.1 | Â |
Tumor stage | |||||
 pT2 | 7764 | 94.2 | 5.2 | 0.6 | < 0.0001 |
 pT3a | 2809 | 88.9 | 9.6 | 1.5 | |
 pT3b-pT4 | 1688 | 85.7 | 11.7 | 2.6 | |
Gleason grade | |||||
  ≤ 3 + 3 | 2072 | 96.4 | 3.3 | 0.3 | < 0.0001 |
 3 + 4 | 6702 | 92.6 | 6.7 | 0.8 | |
 3 + 4 Tertiary 5 | 614 | 91.0 | 8.1 | 0.8 | |
 4 + 3 | 1257 | 88.5 | 9.7 | 1.8 | |
 4 + 3 Tertiary 5 | 925 | 86.3 | 10.9 | 2.8 | |
  ≥ 4 + 4 | 704 | 85.5 | 11.6 | 2.8 | |
Lymph node metastasis | |||||
 N0 | 7604 | 91.3 | 7.5 | 1.2 | < 0.0001 |
 N+ | 943 | 85.9 | 11.7 | 2.4 | |
Preoperative PSA level (ng/ml) | |||||
  < 4 | 1418 | 89.6 | 8.9 | 1.6 | 0.0506 |
 4–10 | 7278 | 92.3 | 6.7 | 1.0 | |
 10–20 | 2629 | 91.8 | 7.2 | 1.0 | |
  > 20 | 918 | 91.8 | 7.3 | 0.9 | |
Surgical margin | |||||
 Negative | 9733 | 92.3 | 6.7 | 1.0 | 0.0011 |
 Positive | 2536 | 90.0 | 8.6 | 1.3 |